Rubric Capital Management LP - 31 Mar 2025 SCHEDULE 13G/A Report for Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares, nominal value $0.000273235 per share (KNSA)

Filing Manager
Rubric Capital Management LP
Reporting Manager
Rubric Capital Management LP
Security
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares, nominal value $0.000273235 per share
Symbol
KNSA
Shares outstanding
42,027,814 shares
Disclosed Ownership
3,383,239 shares
Ownership
8%
Form type
SCHEDULE 13G/A
Filing time
14 May 2025, 16:04:49 UTC
Date of event
31 Mar 2025
Next filing
09 Jul 2025
SEC
View on sec.gov

Quoteable Key Fact

"Rubric Capital Management LP disclosed 8% ownership in Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares, nominal value $0.000273235 per share (KNSA) on 31 Mar 2025."

Quick Takeaways

  • Rubric Capital Management LP filed SCHEDULE 13G/A for Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares, nominal value $0.000273235 per share (KNSA).
  • Disclosed ownership: 8%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 May 2025, 16:04.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Rubric Capital Management LP 8% 3,383,239 0 3,383,239 /s/ Michael Nachmani Michael Nachmani / Chief Operating Officer
David Rosen 8% 3,383,239 0 3,383,239 /s/ David Rosen David Rosen / Individually